Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Mantoulidis

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 25, 2019
KRAS Binders Hidden in NatureAndreas Bergner, Xiaoling Cockcroft, Gerhard Fischer, et al.
Chemmedchem|January 17, 2023
Discovery of a Chemical Probe to Study Implications of BPTF Bromodomain Inhibition in Cellular and in vivo ExperimentsPaola Martinelli, Otmar Schaaf, Andreas Mantoulidis, et al.
Nature|May 31, 2023
Pan-KRAS inhibitor disables oncogenic signalling and tumour growthDongsung Kim, Lorenz Herdeis, Dorothea Rudolph, et al.
Journal of Medicinal Chemistry|October 27, 2022
Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS<sup>G12C</sup> InhibitorJoachim Bröker, Alex G Waterson, Chris Smethurst, et al.
Journal of Medicinal Chemistry|July 25, 2025
Discovery of BI-2493, a Pan-KRAS Inhibitor Showing <i>In Vivo</i> EfficacyJoachim Bröker, Alex G Waterson, Timothy R Hodges, et al.
Nature Communications|March 5, 2024
Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteriaLukas Junk, Volker M Schmiedel, Somraj Guha, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2019
Drugging an undruggable pocket on KRASDirk Kessler, Michael Gmachl, Andreas Mantoulidis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 25, 2019
KRAS Binders Hidden in NatureAndreas Bergner, Xiaoling Cockcroft, Gerhard Fischer, et al.
Chemmedchem|January 17, 2023
Discovery of a Chemical Probe to Study Implications of BPTF Bromodomain Inhibition in Cellular and in vivo ExperimentsPaola Martinelli, Otmar Schaaf, Andreas Mantoulidis, et al.
Nature|May 31, 2023
Pan-KRAS inhibitor disables oncogenic signalling and tumour growthDongsung Kim, Lorenz Herdeis, Dorothea Rudolph, et al.
Journal of Medicinal Chemistry|October 27, 2022
Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS<sup>G12C</sup> InhibitorJoachim Bröker, Alex G Waterson, Chris Smethurst, et al.
Journal of Medicinal Chemistry|July 25, 2025
Discovery of BI-2493, a Pan-KRAS Inhibitor Showing <i>In Vivo</i> EfficacyJoachim Bröker, Alex G Waterson, Timothy R Hodges, et al.
Nature Communications|March 5, 2024
Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteriaLukas Junk, Volker M Schmiedel, Somraj Guha, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2019
Drugging an undruggable pocket on KRASDirk Kessler, Michael Gmachl, Andreas Mantoulidis, et al.
Pageof 1